← Back to Search

Intermittent Fasting for Brain Health

N/A
Waitlist Available
Led By Andriy Yabluchanskiy, MD, PhD
Research Sponsored by University of Oklahoma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adequate hearing and visual acuity to participate in the examinations
Age ≥55 and ≤80 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, up to 6 months
Awards & highlights

Study Summary

This trial studies if eating meals in a restricted timeframe can improve heart & brain health, potentially leading to better thinking skills.

Who is the study for?
This trial is for individuals aged between 55 and 80 who can read, write, and understand English. They should be mentally competent to consent and have a Mini-Mental State Exam score of at least 24. It's not suitable for those with major psychiatric diseases, uncontrolled substance abuse issues, certain diabetics on specific medications, or anyone with recent severe brain-related health events.Check my eligibility
What is being tested?
The study tests if sticking closely to intermittent fasting (eating within a set time frame each day) improves brain function in older adults. The focus is on whether this eating pattern enhances cognitive abilities by improving blood vessel function in the brain through certain protective pathways.See study design
What are the potential side effects?
While the trial itself does not mention specific side effects related to intermittent fasting, common ones may include hunger, fatigue, weakness during fasting periods initially until the body adapts.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can see and hear well enough to take part in exams.
Select...
I am between 55 and 80 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, up to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in EEG spectra
Change in neurovascular coupling using functional near infrared spectroscopy (fNIRS)
Change in neurovascular coupling using the dynamic retinal vessel analysis
Secondary outcome measures
Body composition
Change in Attention
Change in Episodic Memory
+13 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Time restricted eatingExperimental Treatment1 Intervention
not more than 10 hrs. eating window daily goal for 6 months

Find a Location

Who is running the clinical trial?

University of OklahomaLead Sponsor
455 Previous Clinical Trials
97,581 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,672 Previous Clinical Trials
28,018,631 Total Patients Enrolled
Andriy Yabluchanskiy, MD, PhDPrincipal InvestigatorUniversity of Oklahoma
3 Previous Clinical Trials
94 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the objectives of this investigation?

"This medical trial will measure the Change in neurovascular coupling, Transcutaneous deep tissue oxygen saturation, Arterial stiffness (Augmentation Index), and Glycocalyx's Perfused Boundary Region over a 6-month period. These metrics are derived from Dynamic Retinal Vessel Analysis, InSpectra near infrared device, Pulse Wave Analysis approach (SphygmoCor), High Definition Video Camera GlycoCheck respectively."

Answered by AI

Is there a specific demographic that is eligible for participation in this clinical trial?

"This clinical trial is on the search for 32 individuals aged between 55 and 80 who have a history of intermittent fasting."

Answered by AI

Do individuals aged 40 and above meet the requirements of participating in this experiment?

"The patient criteria for this trial necessitates that participants must be aged between 55 and 80. There is one clinical study which enrolls those below 18, and another 248 trials are available to adults over 65."

Answered by AI

Are there any existing vacancies to join this clinical investigation?

"The details listed on clinicaltrials.gov indicate that recruitment for this particular trial has expired. Spanning from August 31st, 2023 to September 5th, 2023, the listing was recently edited and no longer actively searching for patients. Despite this fact, there are 256 other trials still recruiting individuals at present."

Answered by AI
~21 spots leftby Jul 2026